O’FALLON, Mo.--(BUSINESS WIRE)--Synergetics USA, Inc. (NASDAQ: SURG) (“Synergetics” or the “Company”), a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and neurosurgical applications, today announced its results for the third quarter and nine months ended April 30, 2010. The Company reported an increase in the third quarter 2010 sales to $13.9 million and net income of $3.3 million, or $0.13 per diluted share, compared with the third quarter of fiscal 2009 of $13.1 million in sales, $458,000 in net income and $0.02 per diluted share, respectively.
